Acute coronary syndrome (ACS), encompassing ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina (UA), remains a leading cause of morbidity ...
A2 Biotherapeutics Receives U.S. FDA Fast Track Designation for A2B543, a Logic-Gated CAR T-Cell Therapy Enhanced with a Membrane-Tethered IL-12 Booster A2 Biotherapeutics, Inc. (A2 Bio), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results